2,670 Shares of Cardinal Health, Inc. $CAH Purchased by Capstone Capital Management Ltd

Capstone Capital Management Ltd acquired a new position in Cardinal Health, Inc. (NYSE:CAH) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,670 shares of the company’s stock, valued at approximately $594,000.

Other institutional investors also recently modified their holdings of the company. Pinnacle Associates Ltd. raised its position in Cardinal Health by 2.9% in the third quarter. Pinnacle Associates Ltd. now owns 1,404 shares of the company’s stock worth $312,000 after purchasing an additional 39 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Cardinal Health by 2.5% in the 3rd quarter. Nisa Investment Advisors LLC now owns 99,240 shares of the company’s stock valued at $22,081,000 after purchasing an additional 2,394 shares during the period. Robeco Institutional Asset Management B.V. raised its holdings in shares of Cardinal Health by 3.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,130,814 shares of the company’s stock worth $251,606,000 after buying an additional 40,905 shares in the last quarter. Prime Capital Investment Advisors LLC lifted its position in shares of Cardinal Health by 3.5% during the 3rd quarter. Prime Capital Investment Advisors LLC now owns 7,859 shares of the company’s stock worth $1,749,000 after buying an additional 264 shares during the period. Finally, Focused Alpha LLC lifted its position in shares of Cardinal Health by 6.4% during the 3rd quarter. Focused Alpha LLC now owns 2,900 shares of the company’s stock worth $645,000 after buying an additional 175 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Activity at Cardinal Health

In other news, insider Jessica Mayer sold 29,436 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares of the company’s stock, valued at $7,812,220.44. This trade represents a 47.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the completion of the transaction, the chief executive officer directly owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This trade represents a 8.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Trading Up 1.8%

Shares of NYSE CAH opened at $257.15 on Wednesday. The firm has a market capitalization of $59.54 billion, a PE ratio of 35.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.50. Cardinal Health, Inc. has a 1 year low of $156.81 and a 1 year high of $258.30. The firm’s 50-day moving average is $235.21 and its 200-day moving average is $222.94.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were issued a $0.5158 dividend. The ex-dividend date was Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.8%. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Mizuho boosted their price target on Cardinal Health from $250.00 to $280.00 and gave the company an “outperform” rating in a research note on Tuesday. UBS Group increased their price objective on Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a research note on Friday. Royal Bank Of Canada began coverage on Cardinal Health in a report on Wednesday, August 19th. They set an “outperform” rating and a $276.00 price objective for the company. Evercore reissued an “outperform” rating and set a $270.00 price objective on shares of Cardinal Health in a report on Wednesday, August 12th. Finally, TD Cowen boosted their target price on shares of Cardinal Health from $275.00 to $280.00 and gave the company a “buy” rating in a research note on Thursday, August 13th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $269.38.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.